Annual D&A
$292.00 K
+$1000.00+0.34%
31 December 2023
Summary:
Viking Therapeutics annual depreciation & amortization is currently $292.00 thousand, with the most recent change of +$1000.00 (+0.34%) on 31 December 2023. During the last 3 years, it has risen by +$15.00 thousand (+5.42%). VKTX annual D&A is now -1.35% below its all-time high of $296.00 thousand, reached on 31 December 2021.VKTX Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly D&A
$87.00 K
+$12.00 K+16.00%
30 September 2024
Summary:
Viking Therapeutics quarterly depreciation & amortization is currently $87.00 thousand, with the most recent change of +$12.00 thousand (+16.00%) on 30 September 2024. Over the past year, it has increased by +$14.00 thousand (+19.18%). VKTX quarterly D&A is now -38.73% below its all-time high of $142.00 thousand, reached on 30 September 2022.VKTX Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM D&A
$310.00 K
+$14.00 K+4.73%
30 September 2024
Summary:
Viking Therapeutics TTM depreciation & amortization is currently $310.00 thousand, with the most recent change of +$14.00 thousand (+4.73%) on 30 September 2024. Over the past year, it has increased by +$20.00 thousand (+6.90%). VKTX TTM D&A is now -13.65% below its all-time high of $359.00 thousand, reached on 30 June 2023.VKTX TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VKTX Depreciation And Amortization Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +0.3% | +19.2% | +6.9% |
| 3 y3 years | +5.4% | +16.0% | +6.5% |
| 5 y5 years | +100.0% | +31.8% | +59.8% |
VKTX Depreciation And Amortization High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -1.4% | +5.4% | -38.7% | -13.7% | +36.0% | |
| 5 y | 5 years | -1.4% | -38.7% | -13.7% | +59.8% | ||
| alltime | all time | -1.4% | -38.7% | -13.7% | +384.4% |
Viking Therapeutics Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $87.00 K(+16.0%) | $310.00 K(+4.7%) |
| June 2024 | - | $75.00 K(+1.4%) | $296.00 K(+0.7%) |
| Mar 2024 | - | $74.00 K(0.0%) | $294.00 K(+0.7%) |
| Dec 2023 | $292.00 K(+0.3%) | $74.00 K(+1.4%) | $292.00 K(+0.7%) |
| Sept 2023 | - | $73.00 K(0.0%) | $290.00 K(-19.2%) |
| June 2023 | - | $73.00 K(+1.4%) | $359.00 K(+25.5%) |
| Mar 2023 | - | $72.00 K(0.0%) | $286.00 K(-1.7%) |
| Dec 2022 | $291.00 K(-1.7%) | $72.00 K(-49.3%) | $291.00 K(-1.4%) |
| Sept 2022 | - | $142.00 K(>+9900.0%) | $295.00 K(+29.4%) |
| June 2022 | - | $0.00(-100.0%) | $228.00 K(-24.3%) |
| Mar 2022 | - | $77.00 K(+1.3%) | $301.00 K(+1.7%) |
| Dec 2021 | $296.00 K | $76.00 K(+1.3%) | $296.00 K(+1.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2021 | - | $75.00 K(+2.7%) | $291.00 K(+1.7%) |
| June 2021 | - | $73.00 K(+1.4%) | $286.00 K(+1.8%) |
| Mar 2021 | - | $72.00 K(+1.4%) | $281.00 K(+1.4%) |
| Dec 2020 | $277.00 K(+6.5%) | $71.00 K(+1.4%) | $277.00 K(+1.8%) |
| Sept 2020 | - | $70.00 K(+2.9%) | $272.00 K(+1.5%) |
| June 2020 | - | $68.00 K(0.0%) | $268.00 K(+1.5%) |
| Mar 2020 | - | $68.00 K(+3.0%) | $264.00 K(+1.5%) |
| Dec 2019 | $260.00 K(>+9900.0%) | $66.00 K(0.0%) | $260.00 K(+34.0%) |
| Sept 2019 | - | $66.00 K(+3.1%) | $194.00 K(+51.6%) |
| June 2019 | - | $64.00 K(0.0%) | $128.00 K(+100.0%) |
| Mar 2019 | - | $64.00 K | $64.00 K |
| Dec 2018 | $0.00 | - | - |
FAQ
- What is Viking Therapeutics annual depreciation & amortization?
- What is the all time high annual D&A for Viking Therapeutics?
- What is Viking Therapeutics annual D&A year-on-year change?
- What is Viking Therapeutics quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Viking Therapeutics?
- What is Viking Therapeutics quarterly D&A year-on-year change?
- What is Viking Therapeutics TTM depreciation & amortization?
- What is the all time high TTM D&A for Viking Therapeutics?
- What is Viking Therapeutics TTM D&A year-on-year change?
What is Viking Therapeutics annual depreciation & amortization?
The current annual D&A of VKTX is $292.00 K
What is the all time high annual D&A for Viking Therapeutics?
Viking Therapeutics all-time high annual depreciation & amortization is $296.00 K
What is Viking Therapeutics annual D&A year-on-year change?
Over the past year, VKTX annual depreciation & amortization has changed by +$1000.00 (+0.34%)
What is Viking Therapeutics quarterly depreciation & amortization?
The current quarterly D&A of VKTX is $87.00 K
What is the all time high quarterly D&A for Viking Therapeutics?
Viking Therapeutics all-time high quarterly depreciation & amortization is $142.00 K
What is Viking Therapeutics quarterly D&A year-on-year change?
Over the past year, VKTX quarterly depreciation & amortization has changed by +$14.00 K (+19.18%)
What is Viking Therapeutics TTM depreciation & amortization?
The current TTM D&A of VKTX is $310.00 K
What is the all time high TTM D&A for Viking Therapeutics?
Viking Therapeutics all-time high TTM depreciation & amortization is $359.00 K
What is Viking Therapeutics TTM D&A year-on-year change?
Over the past year, VKTX TTM depreciation & amortization has changed by +$20.00 K (+6.90%)